NEWS: 日商环球讯息有限公司台湾分公司很高兴地宣布,已在近日完成更改域名,以提供各位顾客更好的服务。我们的最新网域名是https://cn.gii.tw/
市场调查报告书
商品编码
1114236

分子诊断市场研究报告:按技术(芯片和微阵列、原位杂交、质谱)、产品、应用、最终用户、地区 - 到 2027 年的全球预测 - COVID-19 的累积影响

Molecular Diagnostics Market Research Report by Technology (Chips and Microarrays, In Situ Hybridization, and Mass Spectrometry ), Product, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 221 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

分子诊断的全球市场规模预计将在 2021 年达到 240.9 亿美元,到 2022 年达到 275.5 亿美元,到 2027 年达到 560 亿美元,复合年增长率为 15.09%。预计将继续增长。

市场统计

本报告提供七种主要货币的市场规模和预测:美元、欧元、日元、英镑、澳元、加元和瑞士法郎。拥有现成的货币数据有助于组织领导者做出更好的决策。本报告将 2019 年和 2020 年视为过去年份,将 2021 年视为基准年,将 2022 年视为可能年份,并将 2023-2027 年视为预测期。

市场细分和覆盖范围

本研究报告对分子诊断进行分类,并预测以下每个子市场的收入和趋势:

根据技术,对芯片和微阵列、原位杂交、质谱 (MS)、PCR 和测序的市场进行了调查。

按产品,我们正在研究仪器和试剂。

通过应用,我们正在研究血液筛查、遗传疾病筛查、人类白细胞抗原分型、传染病、微生物学、肿瘤学和药物基因组学。

我们按最终用户调查了医院和实验室。

我们按地区调查了美洲、亚太地区、欧洲和中东/非洲。美洲还探索阿根廷、巴西、加拿大、墨西哥和美国。美国在加利福尼亚州、佛罗里达州、伊利诺伊州、纽约州、俄亥俄州、宾夕法尼亚州和德克萨斯州进行了进一步探索。亚太地区在澳大利亚、中国、印度、印度尼西亚、日本、马来西亚、菲律宾、新加坡、韩国、台湾和泰国得到进一步探索。在法国、德国、意大利、荷兰、卡塔尔、俄罗斯、沙特阿拉伯、南非、西班牙、阿拉伯联合酋长国和英国,进一步探索了欧洲、中东和非洲。

竞争策略窗口

竞争战略窗口分析市场、应用程序和地域的竞争格局,以帮助确定供应商能力与未来增长机会之间的一致性或契合度。它还解释了供应商在预测期内采用併购战略、地域扩张、研发和新产品引进战略以进一步扩大业务和增长的最佳或有利契合。

FPNV定位矩阵

FPNV 定位矩阵根据业务战略(业务增长、行业覆盖、财务稳定性、渠道支持)和产品满意度(性价比、易用性、产品功能、客户情绪)对分子诊断市场的供应商进行排名。它用于根据公司的决策进行评估和分类,并了解竞争格局。

市场份额分析

市场份额分析提供对供应商的分析,考虑他们对整个市场的贡献。与同领域其他厂商相比,您可以了解对整体市场的利润贡献程度。深入了解供应商与其他供应商相比在创收和客户群方面的表现。了解市场份额可以让您了解供应商在基准年的规模和竞争力。它揭示了市场在积累性、碎片化、主导性和兼併特征方面的特征。

本报告提供以下几点见解:

  • 市场渗透率:提供有关主要参与者所服务市场的全面信息。
  • 市场开发:提供有关利润丰厚的新兴市场的详细信息,并分析成熟市场的渗透率
  • 市场多元化:提供有关新产品发布、未开发领域、近期发展和投资的详细信息。
  • 竞争评估和信息:提供对主要参与者的市场份额、战略、产品、认证、监管状态、专利状态和製造能力的深入评估。
  • 产品开发和创新:提供对未来技术、研发活动和突破性产品开发的智力洞察。

本报告将回答以下问题:

  • 全球分子诊断市场的规模和预测如何?
  • 在预测期内,COVID-19 对全球分子诊断市场的影响有哪些?
  • 在预测期内,全球分子诊断市场有哪些产品/细分市场/应用/领域值得投资?
  • 全球分子诊断市场的竞争战略窗口是什么?
  • 全球分子诊断市场有哪些技术趋势和监管框架?
  • 主要供应商在全球分子诊断市场的市场份额是多少?
  • 进入全球分子诊断市场的合适模式和战略举措是什么?

内容

第1章前言

  • 调查目的
  • 市场细分和覆盖范围
  • 调查年份
  • 货币和价格
  • 语言
  • 限制
  • 先决条件
  • 利益相关者

第2章研究方法

  • 定义:研究目的
  • 决策:调查设计
  • 准备:创建调查问卷
  • 收集:数据源
  • 分析:数据解读
  • 公式:数据验证
  • 发布:创建研究报告
  • 重复:更新报告

第 3 章执行摘要

第 4 章市场概述

第 5 章市场洞察

  • 市场动态
    • 驱动程序
      • 传染病和各种癌症的流行 医院获得性感染的流行
      • 政府补贴增加
      • 对即时诊断的需求不断扩大
    • 阻碍因素
      • 缺乏清晰统一的监管框架
      • 训练有素的专业人员效率低下,阻碍了新分子诊断技术的正确使用
    • 商机
      • 提高对疾病早期诊断的认识和分子诊断技术的进步
      • 在新兴国家激活研发活动
    • 任务
      • 新分子诊断药物的批准延迟
      • 与审批流程相关的严格规定
  • COVID-19 的累积影响

第 6 章分子诊断市场:按技术分类

  • 芯片和微阵列
  • 原位杂交
  • 质谱法 (MS)
  • PCR
  • 测序

第 7 章分子诊断市场,按产品分类

  • 设备
  • 试剂

第 8 章分子诊断市场,按应用分类

  • 血液筛查
  • 遗传病筛查
  • 人类白细胞抗原分型
  • 感染
  • 微生物学
  • 肿瘤学
  • 药物基因组学

第 9 章分子诊断市场:按最终用户分类

  • 医院
  • 实验室

第 10 章美洲分子诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 11 章亚太地区分子诊断市场

  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国

第 12 章欧洲、中东和非洲的分子诊断市场

  • 法国
  • 德国
  • 意大利
  • 荷兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯联合酋长国
  • 英国

第 13 章竞争格局

  • FPNV 定位矩阵
    • 象限
    • 业务战略
    • 产品满意度
  • 市场排名分析
  • 主要参与者的市场份额分析
  • 竞争场景
    • 併购
    • 合同、合作和伙伴关係
    • 推出新产品,增强功能
    • 投资、筹款
    • 奖项、表彰、拓展

第 14 章。企业可用性简介

  • Abbott Laboratories
  • ADT Biotech
  • Agilent Technologies Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis Group NV
  • bioMerieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Grifols S.A.
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson
  • LabCorp
  • Myriad Genetics, Inc.
  • Novartis AG
  • Roche Diagnostics Corporation
  • Siemens Healthineers
  • Sysmex Corporation by Oxford Gene Technology
  • Thermo Fisher Scientific Inc.

第15章附录

  • 讨论指南
  • 许可和价格
Product Code: MRR-434CCDA04D48

The Global Molecular Diagnostics Market size was estimated at USD 24.09 billion in 2021 and expected to reach USD 27.55 billion in 2022, and is projected to grow at a CAGR 15.09% to reach USD 56.00 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Molecular Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Chips and Microarrays, In Situ Hybridization, Mass Spectrometry (MS), PCR, and Sequencing.

Based on Product, the market was studied across Instruments and Reagents.

Based on Application, the market was studied across Blood Screening, Genetic Disease Screening, Human Leukocyte Antigen Typing, Infectious Disease, Microbiology, Oncology, and Pharmacogenomics.

Based on End User, the market was studied across Hospitals and Laboratories.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Molecular Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Molecular Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Molecular Diagnostics Market, including Abbott Laboratories, ADT Biotech, Agilent Technologies Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Biocartis Group NV, bioMerieux SA, Danaher Corporation, DiaSorin S.p.A., Grifols S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson, LabCorp, Myriad Genetics, Inc., Novartis AG, Roche Diagnostics Corporation, Siemens Healthineers, Sysmex Corporation by Oxford Gene Technology, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Molecular Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Molecular Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Molecular Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Molecular Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Molecular Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global Molecular Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Molecular Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of infectious diseases and various types of cancers prevalence rate of hospital-acquired infections
      • 5.1.1.2. Escalation in government funding
      • 5.1.1.3. Increasing demand for point of care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of clear and uniform regulatory framework
      • 5.1.2.2. Inefficiency of trained professionals limiting the appropriate use of new molecular diagnostic technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in molecular diagnostics along with increasing awareness towards early disease diagnosis
      • 5.1.3.2. Rising number of R&D activities in the emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Delay in the approval of new molecular diagnostic tests
      • 5.1.4.2. Stringent regulations associated with the approval process
  • 5.2. Cumulative Impact of COVID-19

6. Molecular Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Chips and Microarrays
  • 6.3. In Situ Hybridization
  • 6.4. Mass Spectrometry (MS)
  • 6.5. PCR
  • 6.6. Sequencing

7. Molecular Diagnostics Market, by Product

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents

8. Molecular Diagnostics Market, by Application

  • 8.1. Introduction
  • 8.2. Blood Screening
  • 8.3. Genetic Disease Screening
  • 8.4. Human Leukocyte Antigen Typing
  • 8.5. Infectious Disease
  • 8.6. Microbiology
  • 8.7. Oncology
  • 8.8. Pharmacogenomics

9. Molecular Diagnostics Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Laboratories

10. Americas Molecular Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Molecular Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Molecular Diagnostics Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories
  • 14.2. ADT Biotech
  • 14.3. Agilent Technologies Inc.
  • 14.4. Becton, Dickinson, and Company
  • 14.5. Bio-Rad Laboratories, Inc.
  • 14.6. Biocartis Group NV
  • 14.7. bioMerieux SA
  • 14.8. Danaher Corporation
  • 14.9. DiaSorin S.p.A.
  • 14.10. Grifols S.A.
  • 14.11. Hologic Inc.
  • 14.12. Illumina, Inc.
  • 14.13. Johnson & Johnson
  • 14.14. LabCorp
  • 14.15. Myriad Genetics, Inc.
  • 14.16. Novartis AG
  • 14.17. Roche Diagnostics Corporation
  • 14.18. Siemens Healthineers
  • 14.19. Sysmex Corporation by Oxford Gene Technology
  • 14.20. Thermo Fisher Scientific Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2021 VS 2027 (USD BILLION)
  • FIGURE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2027
  • FIGURE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
  • FIGURE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2027
  • FIGURE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, 2019-2027 (USD BILLION)
  • FIGURE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2019-2027 (USD BILLION)
  • FIGURE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), 2019-2027 (USD BILLION)
  • FIGURE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, 2019-2027 (USD BILLION)
  • FIGURE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2019-2027 (USD BILLION)
  • FIGURE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
  • FIGURE 22. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2027
  • FIGURE 24. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD BILLION)
  • FIGURE 25. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 26. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2019-2027 (USD BILLION)
  • FIGURE 27. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 28. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 29. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 31. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, 2019-2027 (USD BILLION)
  • FIGURE 32. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 33. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, 2019-2027 (USD BILLION)
  • FIGURE 34. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 35. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, 2019-2027 (USD BILLION)
  • FIGURE 36. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 37. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2019-2027 (USD BILLION)
  • FIGURE 38. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 39. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 40. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 41. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 42. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 43. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, 2019-2027 (USD BILLION)
  • FIGURE 44. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 45. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
  • FIGURE 46. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2027
  • FIGURE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2019-2027 (USD BILLION)
  • FIGURE 49. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 50. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2019-2027 (USD BILLION)
  • FIGURE 51. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 52. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 53. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 54. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 56. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 57. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 58. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 59. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 60. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 61. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 62. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2027
  • FIGURE 64. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 65. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 66. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 68. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 69. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 70. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 71. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 72. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 73. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 74. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 75. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 76. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 77. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 78. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 79. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 80. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 81. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
  • FIGURE 82. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 83. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 84. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 85. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 86. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 87. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 88. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 89. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 90. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 91. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 92. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 93. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 94. GLOBAL MOLECULAR DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 95. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 96. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 7. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 9. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 10. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CHIPS AND MICROARRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 12. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 14. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 15. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY REGION, 2019-2027 (USD BILLION)
  • TABLE 17. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 18. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY STATE, 2019-2027 (USD BILLION)
  • TABLE 19. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 20. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY (MS), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 22. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 23. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 24. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 25. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 26. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 27. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 28. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 29. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 30. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 31. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 32. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 33. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 34. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 35. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 36. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 37. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 38. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 39. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 40. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 41. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 42. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 43. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 44. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 45. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 46. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 49. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 50. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 51. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC DISEASE SCREENING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 53. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 54. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 55. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 56. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 58. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 59. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 60. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 61. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 63. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 64. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 65. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 66. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 68. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 69. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 70. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 71. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 73. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 74. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 75. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 76. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 78. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 79. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 80. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 81. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 82. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 84. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 85. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 86. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 87. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 89. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 90. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 91. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 92. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 93. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 94. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 95. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 96. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 97. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 98. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 99. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 100. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 101. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 102. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 103. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 104. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 105. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 106. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 107. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 108. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 109. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 110. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 111. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 112. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 113. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 114. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 115. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 116. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 117. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 118. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 119. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 120. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 121. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 122. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 123. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 124. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 125. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 126. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 127. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 128. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 129. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 130. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 131. AUSTRALIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 132. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 133. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 134. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 135. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 136. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 137. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 138. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 139. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 140. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 141. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 142. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 143. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 144. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 145. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 146. INDONESIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 147. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 148. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 149. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 150. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 151. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 152. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 153. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 154. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 155. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 156. MALAYSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 157. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 158. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 159. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 160. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 161. PHILIPPINES MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 162. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 163. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 164. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 165. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 166. SINGAPORE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 167. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 168. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 169. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 170. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 171. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 172. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 173. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 174. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 175. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 176. TAIWAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 177. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 178. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 179. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 180. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 181. THAILAND MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 188. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 189. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 190. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 191. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 192. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 193. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 194. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 195. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 196. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 197. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 198. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 199. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 200. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 201. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 202. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 203. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 204. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 205. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 206. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 207. NETHERLANDS MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 208. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 209. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 210. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 211. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 212. QATAR MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 213. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 214. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 215. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 216. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 217. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 218. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 219. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 220. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 221. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 222. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 223. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 224. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 225. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 226. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 227. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 228. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 229. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 230. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 231. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 232. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 233. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 234. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 235. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 236. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 237. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 238. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 239. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
  • TABLE 240. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 241. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
  • TABLE 242. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 243. GLOBAL MOLECULAR DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 244. GLOBAL MOLECULAR DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 245. GLOBAL MOLECULAR DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 246. GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING
  • TABLE 247. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 248. GLOBAL MOLECULAR DIAGNOSTICS MARKET MERGER & ACQUISITION
  • TABLE 249. GLOBAL MOLECULAR DIAGNOSTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 250. GLOBAL MOLECULAR DIAGNOSTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 251. GLOBAL MOLECULAR DIAGNOSTICS MARKET INVESTMENT & FUNDING
  • TABLE 252. GLOBAL MOLECULAR DIAGNOSTICS MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 253. GLOBAL MOLECULAR DIAGNOSTICS MARKET: LICENSE & PRICING